Authors: DIMMITT DC HUNT TL SPALITTO AJ CRAMER MB SHAH AK ARUMUGHAM T HAHNE W

Citation: Dc. Dimmitt et al., EFFECT OF INFUSION RATE ON THE PHARMACOKINETICS AND TOLERANCE OF INTRAVENOUS DOLASETRON MESYLATE, The Annals of pharmacotherapy, 32(1), 1998, pp. 39-44

Authors: WHITMORE JB KRIS MG HESKETH PJ GROTE TH DUBOIS DM CRAMER MB HAHNE WF

Citation: Jb. Whitmore et al., RATIONALE FOR THE USE OF A SINGLE FIXED INTRAVENOUS DOLASETRON DOSE FOR THE PREVENTION OF CISPLATIN-INDUCED NAUSEA AND VOMITING - POOLED ANALYSIS OF 14 CLINICAL-TRIALS, Supportive care in cancer, 6(5), 1998, pp. 473-478

Authors: KASIMIS BS TAPAZOGLOU E SCHULMAN P STEWART WH HAHNE WF CRAMER MB

Citation: Bs. Kasimis et al., A DOUBLE-BLIND, RANDOMIZED STUDY OF 2 DIFFERENT DOSAGE REGIMENS OF INTRAVENOUS DOLASETRON IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN CHEMOTHERAPY, Cancer investigation, 15(4), 1997, pp. 304-310

Authors: HESKETH PJ GANDARA DR HESKETH AM FACADA A PEREZ EA WEBBER LM MARTIN LA CRAMER MB HAHNE WF

Citation: Pj. Hesketh et al., DOSE-RANGING EVALUATION OF THE ANTIEMETIC EFFICACY OF INTRAVENOUS DOLASETRON IN PATIENTS RECEIVING CHEMOTHERAPY WITH DOXORUBICIN OR CYCLOPHOSPHAMIDE, Supportive care in cancer, 4(2), 1996, pp. 141-146

Authors: HARMAN GS OMURA GA RYAN K HAINSWORTH JD CRAMER MB HAHNE WF

Citation: Gs. Harman et al., A RANDOMIZED, DOUBLE-BLIND COMPARISON OF SINGLE-DOSE AND DIVIDED MULTIPLE-DOSE DOLASETRON FOR CISPLATIN-INDUCED EMESIS, Cancer chemotherapy and pharmacology, 38(4), 1996, pp. 323-328

Authors: YEILDING A BERTOLI L EISENBERG P PLEZIA P MODIANO MR ALBERTS DS KHOJASTEH A CRAMER MB HAHNE WF

Citation: A. Yeilding et al., ANTIEMETIC EFFICACY OF 2 DIFFERENT SINGLE INTRAVENOUS DOSES OF DOLASETRON IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN-CONTAINING CHEMOTHERAPY, American journal of clinical oncology, 19(6), 1996, pp. 619-623